Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$2.32 - $4.02 $3,456 - $5,989
-1,490 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$1.98 - $5.87 $67 - $199
-34 Reduced 2.23%
1,490 $3,000
Q4 2019

Feb 04, 2020

BUY
$3.36 - $5.04 $141 - $211
42 Added 2.83%
1,524 $9,000
Q3 2019

Nov 12, 2019

BUY
$4.89 - $7.18 $7,246 - $10,640
1,482 New
1,482 $8,000

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.